4.8 Article

Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study

Journal

HEPATOLOGY
Volume 62, Issue 3, Pages 773-783

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1002/hep.27869

Keywords

-

Funding

  1. National Heart, Lung, and Blood Institute
  2. University of Alabama at Birmingham [HHSN268201300025C, HHSN268201300026C]
  3. Northwestern University [HHSN268201300027C]
  4. University of Minnesota [HHSN268201300028C]
  5. Kaiser Foundation Research Institute [HHSN268201300029C]
  6. Johns Hopkins University School of Medicine [HHSN268200900041C]
  7. Intramural Research Program of the National Institute on Aging
  8. National Institutes of Health (NIH) [1 F32 HL116151-01]
  9. American Liver Foundation (New York, NY)
  10. American Association for the Study of Liver Diseases Foundation (Alexandria, VA)
  11. NIH [R01 HL107577]
  12. American Heart Association [13 POST 16820054]

Ask authors/readers for more resources

Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are obesity-related conditions with high cardiovascular mortality. Whether NAFLD is independently associated with subclinical myocardial remodeling or dysfunction among the general population is unknown. We performed a cross-sectional analysis of 2,713 participants from the multicenter, community-based Coronary Artery Risk Development in Young Adults (CARDIA) study who underwent concurrent computed tomography (CT) quantification of liver fat and comprehensive echocardiography with myocardial strain measured by speckle tracking during the Year-25 examination (age, 43-55 years; 58.8% female and 48.0% black). NAFLD was defined as liver attenuation 40 Hounsfield units after excluding other causes of liver fat. Subclinical left ventricular (LV) systolic dysfunction was defined using values of absolute peak global longitudinal strain (GLS). Diastolic dysfunction was defined using Doppler and tissue Doppler imaging markers. Prevalence of NAFLD was 10.0%. Participants with NAFLD had lower early diastolic relaxation (e') velocity (10.8 +/- 2.6 vs. 11.9 +/- 2.8 cm/s), higher LV filling pressure (E/e' ratio: 7.7 +/- 2.6 vs. 7.0 +/- 2.3), and worse absolute GLS (14.2 +/- 2.4% vs. 15.2 +/- 2.4%) than non-NAFLD (P<0.0001 for all). When adjusted for HF risk factors or body mass index, NAFLD remained associated with subclinical myocardial remodeling and dysfunction (P<0.01). The association of NAFLD with e' velocity (=-0.36 [standard error=0.15] cm/s; P=0.02), E/e' ratio (=0.35 [0.16]; P=0.03), and GLS (=-0.42 [0.18]%; P=0.02) was attenuated after controlling for visceral adipose tissue. Effect modification by race and sex was not observed. Conclusions: NAFLD is independently associated with subclinical myocardial remodeling and dysfunction and provides further insight into a possible link between NAFLD and HF. (Hepatology 2015;62:773-783)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available